Counterpoint Mutual Funds’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-87,580
Closed -$2.87M 314
2025
Q4
$2.87M Buy
+87,580
New +$2.15M 0.21% 52
2025
Q2
Sell
-43,302
Closed -$801K 317
2025
Q1
$801K Buy
43,302
+9,027
+26% +$163K 0.11% 69
2024
Q4
$565K Buy
+34,275
New +$485K 0.07% 112

Other funds holding AXGN

Counterpoint Mutual Funds's AXGN Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of Axogen (AXGN) in Q1 2026, closing a stake of 87,580 shares — an estimated $2.87M sold.

Counterpoint Mutual Funds first reported a position in AXGN in Q4 2024 and held it in 3 quarters. The position peaked at $2.87M in Q4 2025. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Counterpoint Mutual Funds reported no remaining Axogen position as of Q1 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 87,580 Axogen shares in Q1 2026, an estimated $2.87M.
  • Counterpoint Mutual Funds first reported a position in Axogen in Q4 2024 and held it in 3 quarters.
  • Counterpoint Mutual Funds's Axogen position peaked at $2.87M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.